First Horizon Advisors’s Immunocore IMCR Stock Holding History

First Horizon Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$17K	Sell	541 -66	-11%	-$2.05K	﹤0.01%	1485
2025 Q1	$18K	Hold	607	–	–	﹤0.01%	1368
2024 Q4	$17.9K	Hold	607	–	–	﹤0.01%	1373
2024 Q3	$18.9K	Hold	607	–	–	﹤0.01%	1382
2024 Q2	$20.6K	Hold	607	–	–	﹤0.01%	1263
2024 Q1	$39.5K	Hold	607	–	–	﹤0.01%	1069
2023 Q4	$41.5K	Buy	607 +115	+23%	+$5.98K	﹤0.01%	1027
2023 Q3	$25.5K	Buy	492 +119	+32%	+$7.04K	﹤0.01%	1146
2023 Q2	$22.4K	Buy	+373	New	+$21.3K	﹤0.01%	1226

Other funds holding IMCR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

First Horizon Advisors's IMCR Position: Q2 2025 in Review

First Horizon Advisors reduced its Immunocore (IMCR) stake by 11% in Q2 2025, selling an estimated $2.05K and leaving 541 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

First Horizon Advisors first reported a position in IMCR in Q2 2023 and has held it in 9 quarters since. The position peaked at $41.5K in Q4 2023. 133 funds tracked by Wall St. Rank hold IMCR as of Q2 2025.

First Horizon Advisors held 541 shares of Immunocore worth $17K as of Q2 2025.
First Horizon Advisors sold 66 Immunocore shares in Q2 2025, an estimated $2.05K.
Immunocore made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1485 holding.
First Horizon Advisors first reported a position in Immunocore in Q2 2023 and has held it in 9 quarters since.
First Horizon Advisors's Immunocore position peaked at $41.5K in Q4 2023.
133 funds tracked by Wall St. Rank held Immunocore as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.